Tag USD

US Endo Pharma wraps up HealthTronics takeover

Jul15

US drug developer Endo Pharmaceuticals (NASDAQ:ENDP) announced yesterday the completion of the acquisition of Austin-based urology company HealthTronics (NASDAQ:HTRN) for USD223m (EUR171.9m) in cash.The acquisition will enable Endo Pharma to expand its product and service offering in urology, the buyer said.Under the terms of the agreement, which includes the assumption of some USD35m in debt, [...]

Novartis delivers strong financial performance in second quarter, underpinned by increased momentum in innovation

Jul14

Novartis International AG / Novartis delivers strong financial performance in second quarter, underpinned by increased momentum in innovation processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. * Double-digit growth in the second quarter with excellent contributions from all divisions * Net [...]

US Select Medical to buy Regency Hospital for USD210m

Jun21

US hospital operator Select Medical Holdings Corporation (NYSE:SEM) said Monday it had inked an agreement to take over local sector firm Regency Hospital Company LLC for some USD210m (EUR169.9m), including part of its debt.Regency, a specialist in the management of long-term acute care hospitals, has been part of Waud Capital Partners.The deal price may be [...]

Universal Health Services agrees acquisition of Psychiatric Solutions Inc

May16

Hospital company Universal Health Services Inc (UHS) (NYSE:UHS) has entered into an agreement to acquire Psychiatric Solutions Inc (PSI) (NASDAQ:PSYS) for approximately USD2.0bn in cash, the two companies announced today.UHS will pay USD33.75 per share to acquire PSI, a behavioural health programmes specialist and operator of psychiatric inpatient facilities.The total value of the transaction is [...]

Universal Health close to buying Psychiatric Solutions for USD2bn

May16

US behavioural healthcare facilities operator Psychiatric Solutions (NASDAQ:PSYS) is nearing a USD2bn (EUR1.6bn) cash deal to be acquired by hospital operator Universal Health Services (NYSE:UHS), Reuters reported on Sunday citing informed sources.As part of the deal, Universal Health will pay USD33.75 per share in cash, one of the insiders said. Based on Friday’s closing price, [...]

M&A Navigator: Deal pipeline

May3

The following is a list a of deals covered in detail by M&A Navigator this week:- US CHEMTURA COMPLETES SALE OF PVC ADDITIVES OPS TO GALATAUS chemical company Chemtura Corporation (OTC:CEMJQ) said it has wrapped up the divestment of its PVC additives operations to newly-established sector firm Galata Chemicals for USD16.2m (EUR12.3m) in cash.Status: Closed- [...]

Novartis healthcare portfolio generates strong growth in first quarter of 2010, progress on delivering innovation, growth and productivity

Apr19

Novartis International AG / Novartis healthcare portfolio generates strong growth in first quarter of 2010, progress on delivering innovation, growth and productivity processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. * Portfolio rejuvenation underpins positive momentum in first quarter of 2010: [...]

Critical Homecare Solutions acquired by BioScrip

Mar28

Pharmaceutical services company BioScrip Inc (NASDAQ:BIOS) reported on Thursday that it has completed its acquisition of Critical Homecare Solutions Holdings Inc (CHS), a provider of home infusion and home nursing products and services to patients suffering from chronic and acute medical conditions.The purchase price was USD237.9m in cash plus USD109.8m of BioScrip common stock, or [...]

US BioScrip closes Critical Homecare Solutions buy

Mar25

US pharmaceutical services company BioScrip (NASDAQ:BIOS) announced on Thursday it had wrapped up the purchase of home Critical Homecare Solutions Holdings, or CHS, providing home infusion and home nursing products and services to chronically ill.BioScrip paid USD237.9m (EUR178.3m) cash and 13.1 million shares worth USD109.8m for the acquisition. It had also issued 3.4 million five-year [...]

Israeli Teva agrees to pay EUR3.5bn for German Ratiopharm

Mar17

German generic drugs producer Ratiopharm said today its owners agreed to sell it to Israel-based drug maker Teva (TLV:TEVA) for over EUR3.5bn (USD4.8bn).Thus Teva outpaced in the race for Ratiopharm its two other suitors – US pharma major Pfizer Inc (NYSE:PFE) and Iceland-based Actavis.With Ratiopharm the Israeli company will have staff of 40,000 worldwide. Their [...]

Your Ad Here